The Role of Anti-B Cell Activating Factor Therapy for Treating Lupus Nephritis
Clin J Am Soc Nephrol
.
2022 Nov;17(11):1583-1585.
doi: 10.2215/CJN.11340922.
Epub 2022 Oct 27.
Authors
Benjamin Wooden
1
,
Jai Radhakrishnan
Affiliation
1
Division of Nephrology, Columbia University, New York, New York.
PMID:
36302568
PMCID:
PMC9718047
DOI:
10.2215/CJN.11340922
No abstract available
Keywords:
belimumab; immunosuppression; systemic lupus erythematosus; voclosporin.
Publication types
Editorial
Comment
MeSH terms
Humans
Immunosuppressive Agents / therapeutic use
Lupus Erythematosus, Systemic*
Lupus Nephritis* / drug therapy
Treatment Outcome
Substances
Immunosuppressive Agents